Inventor · disambiguated record
Roland Koestler
Also filed as: KOESTLER ROLAND
4 granted patents·5 pending applications·4 citations·filing 2012–2025
62Inventor score
Top patents by PatentIndex Score
9 records- 0169US10000482B2Kinase inhibitorsORIGENIS GMBH·Filed 2013·Granted Jun 19, 2018·2 cites·21 claims
- 0267US9499535B2Kinase inhibitorsTHORMANN MICHAEL·Filed 2012·Granted Nov 22, 2016·2 cites·14 claims
- 0366US2025361237A11,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune diseaseORIGENIS GMBH·Filed 2025·Application pending·0 cites
- 0462US10752624B2Kinase inhibitorsORIGENIS GMBH·Filed 2018·Granted Aug 25, 2020·0 cites·7 claims
- 0556US12384788B21,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as LRRK2, NUAK1 and/or TYK2 kinase modulators for the treatment of e.g. autoimmune diseaseORIGENIS GMBH·Filed 2020·Granted Aug 12, 2025·0 cites·20 claims
- 0652US2025019382A1Novel inhibitors of cyclin-dependent kinasesORIGENIS GMBH·Filed 2022·Application pending·0 cites
- 0750US2024067655A1Kinase modulators and methods of use thereofNEURON23 INC·Filed 2021·Application pending·0 cites
- 0847US2023373985A1Kinase modulators and methods of use thereofORIGENIS GMBH·Filed 2021·Application pending·0 cites
- 0944US2022380374A11,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune diseaseORIGENIS GMBH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roland Koestler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →